Skip to Content

PT Kimia Farma Tbk Class B KAEF

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

KAEF is trading at a 473% premium.
Price
IDR 639.97
Fair Value
IDR 3,413.70
Uncertainty
Very High
1-Star Price
IDR 1,273.51
5-Star Price
IDR 634.36
Economic Moat
Xdz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KAEF is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.36
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Small Value
Total Number of Employees
11,181

Comparables

Valuation

Metric
KAEF
OMED
NCKL
Price/Earnings (Normalized)
19.8410.60
Price/Book Value
0.612.232.35
Price/Sales
0.362.882.30
Price/Cash Flow
13.8516.448.96
Price/Earnings
KAEF
OMED
NCKL

Financial Strength

Metric
KAEF
OMED
NCKL
Quick Ratio
0.2810.680.74
Current Ratio
0.5815.551.29
Interest Coverage
−2.6516.1611.08
Quick Ratio
KAEF
OMED
NCKL

Profitability

Metric
KAEF
OMED
NCKL
Return on Assets (Normalized)
−9.52%10.67%15.16%
Return on Equity (Normalized)
−26.85%12.42%30.35%
Return on Invested Capital (Normalized)
−8.16%10.45%20.43%
Return on Assets
KAEF
OMED
NCKL
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
McKesson Corp
MCK
GqprcdrqPhyfbl$76.0 Bil
Cencora Inc
COR
HjxgvnbgWdytzry$44.2 Bil
Cardinal Health Inc
CAH
DtvwqmbkHhyrt$23.3 Bil
Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
Ypqztz$8.8 Bil
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
Lbdqdjm$8.8 Bil
Sinopharm Group Co Ltd ADR
SHTDY
Kykntv$7.5 Bil
Sinopharm Group Co Ltd
SHTDF
Hmzfmc$7.5 Bil
Amplifon SpA Az nom Post Frazionamento
AMFPF
Sjptty$7.5 Bil
Medipal Holdings Corp ADR
MAHLY
Bdlq$3.6 Bil
Medipal Holdings Corp
MEPDF
Djf$3.6 Bil

Sponsor Center